High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients

Amplification of the fibroblast growth factor receptor 1 (FGFR1) is believed to predict response to FGFR inhibitors. The aim of this study was to investigate the frequency and the prognostic impact of FGFR1 amplification in patients with resected esophageal squamous cell carcinoma (ESCC) by using fl...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Qi, Liu, Yalan, Jiang, Dongxian, Wang, Haixing, Huang, Jie, Xu, Yifan, Sujie, Akesu, Zeng, Haiying, Xu, Chen, Hou, Yingyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650361/
https://www.ncbi.nlm.nih.gov/pubmed/29088806
http://dx.doi.org/10.18632/oncotarget.20215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650361/
https://www.ncbi.nlm.nih.gov/pubmed/29088806
http://dx.doi.org/10.18632/oncotarget.20215

Ejemplares similares